[Effect of drugs used in the treatment of thrombotic and hemorrhagic conditions on the erythrocyte aggregation].
D015110:4-Hydroxycoumarins / Q000494:pharmacology; D015119:Aminocaproic Acid / Q000494:pharmacology; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D002809:Chondroitin Sulfates / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology; D004903:Erythrocyte Aggregation / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D013300:Streptokinase / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology
D015110:4-Hydroxycoumarins; D000925:Anticoagulants; D003374:Coumarins; D005343:Fibrinolytic Agents; D009578:Nitrobenzenes; D006493:Heparin; D002809:Chondroitin Sulfates; D013300:Streptokinase; D013917:Thrombin; D015119:Aminocaproic Acid
Issledovanie deĭstviia na agregatsiiu eritrotsitov sredstv, primeniaemykh v terapii tromboticheskikh i gemorragicheskikh sostoianii.